G. Amidon, H. Lennernäs, V. Shah, and J. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
B. Bahloul, M.A. Lassoued, and S. Sfar A novel approach for the development and optimization of self emulsifying drug delivery system using HLB and response surface methodology: application to fenofibrate encapsulation Int. J. Pharm. 466 2014 341 348
M. Brion, S. Jaspart, L. Perrone, G. Piel, and B. Evrard The supercritical micronization of solid dispersions by particles from gas saturated solutions using experimental design J. Supercrit. Fluids 51 2009 50 56
J. Brouwers, M.E. Brewster, and P. Augustijns Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J. Pharm. Sci. 98 2009 2549 2572
Y.-M. Chen, P.-C. Lin, M. Tang, and Y.-P. Chen Solid solubility of antilipemic agents and micronization of gemfibrozil in supercritical carbon dioxide J. Supercrit. Fluids 52 2010 175 182
W. Chen, X. Hu, Y. Hong, Y. Su, H. Wang, and J. Li Ibuprofen nanoparticles prepared by a PGSS™-based method Powder Technol. 245 2013 241 250
S.V. Dalvi, M.A. Azad, and R. Dave Precipitation and stabilization of ultrafine particles of fenofibrate in aqueous suspensions by RESOLV Powder Technol. 236 2013 75 84
R. Devraj, H.D. Williams, D.B. Warren, K. Mohsin, C.J.H. Porter, and C.W. Pouton In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine Eur. J. Pharm. Sci. 49 2013 748 760
M. di Cagno, and B. Luppi Drug supersaturation states induced by polymeric micelles and liposomes: a mechanistic investigation into permeability enhancements Eur. J. Pharm. Sci. 48 2013 775 780
Y. Dong, W.K. Ng, J. Hu, S. Shen, and R.B.H. Tan Continuous production of redispersible and rapidly-dissolved fenofibrate nanoformulation by combination of microfluidics and spray drying Powder Technol. 268 2014 424 428
M. El-Badry, G. Fetih, and M. Fathy Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000 Saudi Pharm. J. 17 2009 217 225
J. Fages, H. Lochard, J.-J. Letourneau, M. Sauceau, and E. Rodier Particle generation for pharmaceutical applications using supercritical fluid technology Powder Technol. 141 2004 219 226
M. Fraile, ÿ. Martín, D. Deodato, S. Rodriguez-Rojo, I.D. Nogueira, A.L. Simplício, M.J. Cocero, and C.M.M. Duarte Production of new hybrid systems for drug delivery by PGSS (Particles from Gas Saturated Solutions) process J. Supercrit. Fluids 81 2013 226 235
B.T. Griffin, M. Kuentz, M. Vertzoni, E.S. Kostewicz, Y. Fei, W. Faisal, C. Stillhart, C.M. O'Driscoll, C. Reppas, and J.B. Dressman Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate Eur. J. Pharm. Biopharm. 86 2014 427 437
Y. Hakuta, H. Hayashi, and K. Arai Fine particle formation using supercritical fluids Curr. Opin. Solid State Mater. Sci. 7 2003 341 351
A. Heinz, K.C. Gordon, C.M. McGoverin, T. Rades, and C.J. Strachan Understanding the solid-state forms of fenofibrate - a spectroscopic and computational study Eur. J. Pharm. Biopharm. 71 2009 100 108
S. Hiendrawan, B. Veriansyah, and R.R. Tjandrawinata Micronization of fenofibrate by rapid expansion of supercritical solution J. Ind. Eng. Chem. 20 2014 54 60
H.-H. Jeong, and H.-S. Byun Experimental measurement of cloud-point and bubble-point for the {poly(isobornyl methacrylate) + supercritical solvents + co-solvent} system at high pressure J. Chem. Thermodyn. 75 2014 25 32
J. Jung, and M. Perrut Particle design using supercritical fluids: literature and patent survey J. Supercrit. Fluids 20 2001 179 219
S. Kalepu, M. Manthina, and V. Padavala Oral lipid-based drug delivery systems - an overview Acta Pharm. Sin. B 3 2013 361 372
A. Kalivoda, M. Fischbach, and P. Kleinebudde Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion Int. J. Pharm. 429 2012 58 68
Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, and S. Onoue Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications Int. J. Pharm. 420 2011 1 10
J. Kerč, S. Srčič, Ž. Knez, and P. Senčar-Božič Micronization of drugs using supercritical carbon dioxide Int. J. Pharm. 182 1999 33 39
R. Kinget, and H. De Greef In vitro assessment of drug release from semi-solid lipid matrices Eur. J. Pharm. Sci. 3 1995 105 111
Ž. Knez, M. Škerget, M. Knez Hrnčič, and D. Čuček Chapter 2 - particle formation using sub- and supercritical fluids V.A. Fan, Supercritical Fluid Technology for Energy and Environmental Applications 2014 Elsevier Boston 31 67
C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60
H. Mu, R. Holm, and A. Müllertz Lipid-based formulations for oral administration of poorly water-soluble drugs Int. J. Pharm. 453 2013 215 224
X. Niu, L. Wan, Z. Hou, T. Wang, C. Sun, J. Sun, P. Zhao, T. Jiang, and S. Wang Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability Int. J. Pharm. 452 2013 382 389
D.J. Phillips, S.R. Pygall, V.B. Cooper, and J.C. Mann Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems J. Pharm. Pharmacol. 64 2012 1549 1559
V. Pillay, and R. Fassihi A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug Pharm. Res. 16 1999 333 337
C.W. Pouton, and C.J.H. Porter Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv. Drug Delivery Rev. 60 2008 625 637
A.R. Sampaio de Sousa, A.L. Simplício, H.C. de Sousa, and C.M.M. Duarte Preparation of glyceryl monostearate-based particles by PGSS® - application to caffeine J. Supercrit. Fluids 43 2007 120 125
G.P. Sanganwar, and R.B. Gupta Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide Int. J. Pharm. 360 2008 213 218
P. Senčar-Božič, S. Srčič, Z. Knez, and J. Kerč Improvement of nifedipine dissolution characteristics using supercritical CO2 Int. J. Pharm. 148 1997 123 130
Y. Shi, P. Gao, Y. Gong, and H. Ping Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption Mol. Pharm. 7 2010 1458 1465
M. Strumendo, A. Bertucco, and N. Elvassore Modeling of particle formation processes using gas saturated solution atomization J. Supercrit. Fluids 41 2007 115 125
N. Thomas, K. Richter, T. Pedersen, R. Holm, A. Müllertz, and T. Rades In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate AAPS J. 16 2014 539 549
US Department of Health and Human Services, F.D.A., Center for Drug Evaluation and Research, 1997. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms.
S. Vangani, X. Li, P. Zhou, M.-A. Del-Barrio, R. Chiu, N. Cauchon, P. Gao, C. Medina, and B. Jasti Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic system Clin. Res. Regul. Aff. 26 2009 8 19
T. Vasconcelos, B. Sarmento, and P. Costa Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today 12 2007 1068 1075
C.L.-N. Vo, C. Park, and B.-J. Lee Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs Eur. J. Pharm. Biopharm. 85 2013 799 813
H. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Müllertz, C. Pouton, and C.H. Porter Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations Pharm. Res. 30 2013 3059 3076